Skip to main content

Test guide

Alpha-Fetoprotein (AFP): Tumor Marker, Pregnancy and Limits

AFP is a protein measured in blood. Its meaning depends on why it was tested: an adult tumour-marker result and a pregnancy screen answer different questions.

Published by LongevityMate Editorial · Updated 2026-10-24 · 4 minute read

The short answer

What the evidence helps you understand

AFP, or alpha-fetoprotein, is a protein normally abundant during fetal development and much lower in most nonpregnant adults. It can be measured as a tumour marker or in pregnancy screening. A high result does not establish cancer, and a normal result cannot exclude it. Start with the purpose written on the request and report.See reference 1,See reference 2

Conceptual illustration of a liver and an AFP-labelled blood-sample tube; no patient value, tumour or diagnosis is depicted.
On this page

One protein, two different testing contexts

Context
Tumour-marker testing
What the result contributes
Supports assessment or monitoring alongside other findings; it is not a stand-alone diagnosisSee reference 1
Context
Maternal serum screening
What the result contributes
Estimates the chance of certain fetal conditions in a pregnancy-specific assessment; it is not a diagnosisSee reference 2
Context
An adult reference interval
What the result contributes
Must not be used to classify a pregnancy-screening resultSee reference 3

High and normal results each have limits

AFP can rise with some liver and germ-cell tumours, but also with noncancerous liver conditions such as hepatitis or cirrhosis. Some relevant cancers do not produce a raised AFP. Neither an isolated elevation nor an in-range result can settle the diagnosis.See reference 1

NCI describes both false-positive and false-negative screening results. Whether surveillance is appropriate depends on the person’s risk and care plan. An AFP test offered as part of targeted care is different from a general cancer check for a healthy population.See reference 4

Read the units, method and reference interval together

For its serum tumour-marker assay, Mayo Clinic Laboratories lists a reference value below 8.4 ng/mL for nonpregnant subjects. That is one laboratory’s assay-specific reference information, not a universal cancer threshold or an optimal longevity target.See reference 3

Mayo notes that values can vary by method and that serum markers are not specific for malignancy. Keep the original unit, laboratory and method when comparing reports. A change of test method can complicate a numerical comparison; ask the clinical team whether results are comparable.See reference 3

Pregnancy screening needs its own interpretation

During pregnancy, AFP reaches the maternal blood from the developing baby. Interpretation depends on gestational timing and the wider screen. A different estimated due date or a multiple pregnancy can change the expected result. An abnormal screen signals a need to discuss further assessment rather than confirming a fetal condition.See reference 2

The tumour-marker assay described by Mayo is explicitly not intended to detect neural tube defects. The same abbreviation therefore does not make two orders interchangeable. Check whether the report says tumour marker, maternal serum screening or another specific test.See reference 3

Useful details to bring to a discussion

Detail
Reason for the test
Why it matters
Separates targeted cancer care from a pregnancy screenSee reference 1,See reference 2
Detail
Exact test name, unit, method and laboratory interval
Why it matters
Prevents comparison across incompatible reportsSee reference 3
Detail
Previous results and the agreed follow-up plan
Why it matters
Places a screening signal within the wider assessmentSee reference 4

Preparation follows the actual order

An AFP blood test alone generally needs no special preparation. Follow the collection instructions for other tests taken at the same appointment, and tell the team about medicines and supplements. This guide does not advise stopping a treatment.See reference 2

Keep the useful details

Common questions

Does high AFP mean liver cancer?

No. Noncancerous liver disease and other contexts can raise it. Diagnosis requires the wider clinical assessment.See reference 1

Can AFP be normal when cancer is present?

Yes. NCI describes false-negative screening results, including normal findings despite liver cancer.See reference 4

Is a low adult AFP an anti-ageing goal?

The cited assay is a tumour-marker test with a defined clinical purpose. It does not establish an optimal anti-ageing target.See reference 3

Get the weekly longevity brief

The week's best longevity research in plain English. Free, every Tuesday.

See your blood results in context

If you already have blood test results, the paid LongevityMate app can help you view related markers together. It provides educational context, not a diagnosis or a replacement for your clinician.

Explore blood test analysis

References

  1. 1. Alpha fetoprotein (AFP) tumor marker test

    MedlinePlus, U.S. National Library of MedicineOfficial guidance

  2. 2. Alpha-fetoprotein (AFP) test in pregnancy

    MedlinePlus, U.S. National Library of MedicineOfficial guidance

  3. 3. AFP: Alpha-fetoprotein tumor marker, serum

    Mayo Clinic LaboratoriesOfficial guidance

  4. 4. Liver cancer screening

    U.S. National Cancer InstituteOfficial guidance

Editorial transparency

Published by
LongevityMate Editorial
Review
Editorial evidence review (AI-assisted)
Published
Updated

Medical disclaimer

General education only. AI-assisted editorial evidence review is not a qualified clinical assessment. This guide does not diagnose a condition, interpret a personal result, choose treatment or recommend a supplement dose. Discuss testing, symptoms, medicines and supplements with a qualified health professional.